TrialNeuroImage. Clinical2020

Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients.

Sebastian Regnery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.